MedPath

Influence on the lower urinary tract function of the cross sex hormone therapy for the Female to Male patient in gender identity disorders

Not Applicable
Recruiting
Conditions
Female to Male of gender identity disorders
Registration Number
JPRN-UMIN000006933
Lead Sponsor
Department of Urology, Nagoya University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

The patient who cannot accept inspection. The pregnancy or the patient who may be pregnant. The patient with the previous hormone therapy. The patient cannot contact continuously. The patient is not gender identity disorders and have possibility of serious diseases to adversely affect with hormone therapy. The patient who performed a sex reassignment surgery or the planned patient who perform a sex reassignment surgery in a study. The patient who is excluded to hormone therapy in "the guidelines on diagnosis and treatment third edition about gender identity disorders."

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Volume of esidual urine, Urination frequency, IPSS score, IPSS-QOL score, OABSS score
Secondary Outcome Measures
NameTimeMethod
period to cessation of menses
© Copyright 2025. All Rights Reserved by MedPath